A “unifying” hypothesis of the mechanisms, triggers, and risk factors for myalgic encephalomyelitis (ME), is gaining support. Further evaluation and development of a potential drug depend on funding. Read more…
Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.